How CD47 Antibody Therapies Are Advancing Cancer Immunotherapy,...

added blog Wellness

2026-09-02 09:28:42 - Translate -

How CD47 Antibody Therapies Are Advancing Cancer Immunotherapy, Autoimmune Disease Treatment, and Personalized Medicine

The global leukocyte surface antigen CD47 antibody market is expanding as healthcare providers, pharmaceutical companies, and research institutions invest in advanced therapeutic solutions to address the rising incidence of cancer and improve patient outcomes. The market was valued at USD 1.3 billion in 2025 and is projected to reach USD 3.5 billion by 2035, growing at a CAGR of 10.6%. The...

0 Comments 0 Shares 52 Views 0 Reviews